July 3 (Reuters) - Abbvie Inc ABBV.N:
ABBVIE INC - REPORTS $823 MILLION IPR&D AND MILESTONES EXPENSE FOR Q2 2025 - SEC FILING
ABBVIE INC - EXPENSE IMPACTS Q2 GAAP AND NON-GAAP EPS BY $0.42 - SEC FILING
ABBVIE INC - 2025 ADJUSTED EPS GUIDANCE RANGE IS $11.67 - $11.87 - SEC FILING
ABBVIE INC - Q2 2025 ADJUSTED EPS GUIDANCE RANGE IS $2.84 - $2.88 - SEC FILING
Source text: [ID:n0001551152-25-000034]
Further company coverage: ABBV.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.